# Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis

> **NCT06611696** · PHASE4 · RECRUITING · sponsor: **Chiba University** · enrollment: 160 (estimated)

## Conditions studied

- ANCA Associated Vasculitis (AAV)

## Interventions

- **DRUG:** Avacopan, prednisolone and rituximab
- **DRUG:** Prednisolone and rituximab

## Key facts

- **NCT ID:** NCT06611696
- **Lead sponsor:** Chiba University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-15
- **Primary completion:** 2027-03-31
- **Final completion:** 2028-09-30
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2025-05-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06611696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06611696, "Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06611696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*